Forte Biosciences Inc.

7.75
-1.35 (-14.84%)
At close: Mar 03, 2025, 3:59 PM
7.68
-0.90%
After-hours: Mar 03, 2025, 04:00 PM EST

Forte Biosciences Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -31.48M -13.88M -21.71M -46.49M -4.07M -48.95M -38.93M -33.48M -23.06M
Depreciation & Amortization 9K n/a 36K 54K 11K 625K 292K 255K 232K
Stock-Based Compensation 3.28M 4.01M 4.21M 956K 35.71K 6.87M 4.45M n/a n/a
Other Working Capital -663K 1.47M 1.01M -3.46M 274.84K 4.82M 2.21M 1.28M 176K
Other Non-Cash Items -131K 3.81M 61K 30.89M -918K 7.77M 5.26M 1.74M 928K
Deferred Income Tax n/a n/a n/a n/a 918K -6.87M -4.45M n/a n/a
Change in Working Capital -392K 1.68M 720K -3.83M 1.25M 6.08M 2.52M 1.87M 747K
Operating Cash Flow -28.71M -8.19M -16.68M -18.42M -2.77M -34.47M -31.13M -29.54M -21.04M
Capital Expenditures -88K n/a n/a n/a -161.6K -1.97M -655K -525K -231K
Acquisitions n/a n/a n/a 3.58K n/a 2.22M 20K n/a 15K
Purchase of Investments -9.96M n/a n/a n/a n/a -70.75M -70.8M -23M -59.87M
Sales Maturities Of Investments 10.1M n/a n/a n/a n/a 68.52M 43.73M 48.09M 35.16M
Other Investing Acitivies n/a n/a n/a 3.58M 42.32M -2.22M -27.05M 25.09M -24.7M
Investing Cash Flow 47K n/a n/a 3.58M -161.6K -4.19M -27.71M 24.57M -24.93M
Debt Repayment n/a n/a n/a n/a n/a 23.32M 138K 2.91M 50.74M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a 89K 3.38M 33.23M
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -28K 12K -44K -32K 4.86M -8.63M n/a -592K -982K
Financial Cash Flow 24.68M 7.24M -44K 66.67M 4.86M 43.54M 89.26M 2.33M 49.92M
Net Cash Flow -3.98M -944K -16.72M 51.83M 1.92M 4.88M 30.42M -2.64M 3.95M
Free Cash Flow -28.79M -8.19M -16.68M -18.42M -2.93M -36.44M -31.79M -30.06M -21.27M